Related references
Note: Only part of the references are listed.INCIDENCE OF ACUTE ENDOPHTHALMITIS AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN A SINGLE CLINICAL CENTER
Khalil Ghasemi Falavarjani et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Avastin Doesn't Blind People, People Blind People
Serafin Gonzalez et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of Bevacizumab
Roger A. Goldberg et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Reactivation of Retinopathy of Prematurity After Bevacizumab Injection
Jennifer Hu et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction
Aparna Ramasubramanian et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?
Kleanthis Manousaridis et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Prevention of postcataract endophthalmitis: evidence-based medicine
Charles Q. Yu et al.
CURRENT OPINION IN OPHTHALMOLOGY (2012)
Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity
B. J. Lee et al.
EYE (2012)
Endophthalmitis following intravitreal injections
Cristina Irigoyen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Secondary rhegmatogenous retinal detachment following intravitreal bevacizumab in patients with vitreous hemorrhage or tractional retinal detachment secondary to Eales' disease
Atul Kumar et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma
Tomomi Higashide et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Changes in Antibiotic Resistance Patterns of Conjunctival Flora Due to Repeated Use of Topical Antibiotics after Intravitreal Injection
Eugene Milder et al.
OPHTHALMOLOGY (2012)
Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Quan V. Hoang et al.
OPHTHALMOLOGY (2012)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
Christine Schmucker et al.
PLOS ONE (2012)
Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections
Carsten H. Meyer et al.
ACTA OPHTHALMOLOGICA (2011)
Systemic and Kidney Toxicity of Intraocular Administration of Vascular Endothelial Growth Factor Inhibitors
Gaelle Pelle et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Emerging Evidence Concerning Systemic Safety of Anti-VEGF Agents - Should Ophthalmologists Be Concerned?
Laurence S. Lim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Survey of Intravitreal Injection Techniques Among Retinal Specialists in the United States
Amy E. Green-Simms et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Bacterial Dispersal Associated With Speech in the Setting of Intravitreous Injections
Joanne C. Wen et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review
Christine Schmucker et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
Travis J. Good et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema
Michael R. R. Boehm et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan
Wei-Chi Wu et al.
OPHTHALMOLOGY (2011)
Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
Chirag P. Shah et al.
OPHTHALMOLOGY (2011)
Incidence of Retinal Pigment Epithelial Tears after Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration
Emmett T. Cunningham et al.
OPHTHALMOLOGY (2011)
A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
Margriet I. Van der Reis et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS A Six-Year Experience at a University Referral Center
Andrew A. Moshfeghi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
META-ANALYSIS OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS Causative Organisms and Possible Prevention Strategies
Colin A. McCannel
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Michael Tolentino
SURVEY OF OPHTHALMOLOGY (2011)
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
J. Fernando Arevalo et al.
JOURNAL OF OPHTHALMOLOGY (2011)
Role of intravitreal bevacizumab in adult onset Coats’ disease
Neha Goel et al.
INTERNATIONAL OPHTHALMOLOGY (2011)
Retinal vascular events after intravitreal bevacizumab
Ahmad M. Mansour et al.
ACTA OPHTHALMOLOGICA (2010)
Retinal artery occlusion following intravitreal anti-VEGF therapy
Therese von Hanno et al.
ACTA OPHTHALMOLOGICA (2010)
Clinical safety of ranibizumab in age-related macular degeneration
Ursula Schmidt-Erfurth
EXPERT OPINION ON DRUG SAFETY (2010)
Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy
K. Ghasemi Falavarjani et al.
EYE (2010)
A review of clinical trials of anti-VEGF agents for diabetic retinopathy
Benjamin P. Nicholson et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage
Hossein Nazari et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Dicephalic Parapagus Conjoined Twins: A Rare Second Trimester Sonographic Diagnosis
Ahmet Mete et al.
JOURNAL OF CLINICAL ULTRASOUND (2010)
Hemorrhagic Complications after Intravitreal Injections of Ranibizumab in Patients under Coumarin-Type Anticoagulation
V. Loukopoulos et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2010)
Retinal-Vein Occlusion.
Tien Y. Wong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ghost Cell Glaucoma After Intravitreal Bevacizumab for Postoperative Vitreous Hemorrhage Following Vitrectomy for Proliferative Diabetic Retinopathy
Laura Lin et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2010)
Acute Vision Loss after Intravitreal Injection of Bevacizumab (Avastin) Associated with Ocular Ischemic Syndrome
Zei-Lun Huang et al.
OPHTHALMOLOGICA (2010)
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
CLINICAL CHARACTERISTICS OF ENDOPHTHALMITIS AFTER AN INJECTION OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
Daphna Mezad-Koursh et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
INCIDENCE OF HEMORRHAGIC COMPLICATIONS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) OR RANIBIZUMAB (LUCENTIS) INJECTIONS ON SYSTEMICALLY ANTICOAGULATED PATIENTS
John O. Mason et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Erectile Dysfunction Following Intravitreal Bevacizumab
Jayshan Yohendran et al.
MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY (2010)
Isolated Sixth Nerve Palsy After Intravitreal Bevacizumab Injection
Hasan Basri Cakmak et al.
STRABISMUS (2010)
Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapies
Karl Csaky et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (AvastinA®) for treatment of angoid streaks in pseudoxanthoma elasticum
Martin Ganssauge et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Short-term Effect of Intravitreal Injection of Ranibizumab (Lucentis) on Intraocular Pressure
Maurizio Gismondi et al.
JOURNAL OF GLAUCOMA (2009)
Anterior Ischemic Optic Neuropathy After Intravitreal Injection of Bevacizumab
Hamid Hosseini et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2009)
Sustained Elevation in Intraocular Pressure Associated With Intravitreal Bevacizumab Injections
Malik Y. Kahook et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2009)
Large Subretinal Haemorrhage following Change from Intravitreal Bevacizumab to Ranibizumab
Dimitrios A. Karagiannis et al.
OPHTHALMOLOGICA (2009)
Intravitreal Ranibizumab May Induce Retinal Arteriolar Vasoconstriction in Patients with Neovascular Age-related Macular Degeneration
Domniki N. Papadopoulou et al.
OPHTHALMOLOGY (2009)
Microincision Vitrectomy Surgery and Intravitreal Bevacizumab as a Surgical Adjunct to Treat Diabetic Traction Retinal Detachment
Yusuke Oshima et al.
OPHTHALMOLOGY (2009)
INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTS
Teresa Diago et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
RETINAL PIGMENT EPITHELIAL TEARS IN RANIBIZUMAB-TREATED EYES
Bradley T. Smith et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
INTRAVITREAL INJECTION OF 2.5 MG VERSUS 1.25 MG BEVACIZUMAB (AVASTIN) FOR TREATMENT OF CNV ASSOCIATED WITH AMD
Mehdi Modarres et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB Our Experience After 2,000 Injections
Ioannis D. Ladas et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
BEVACIZUMAB PRETREATMENT IN VITRECTOMY WITH SILICONE OIL FOR SEVERE DIABETIC RETINOPATHY
Po-Ting Yeh et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab
S. J. Bakri et al.
EYE (2009)
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting
Suman Pilu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity
Shigeru Honda et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration
Michael S. Ip et al.
OPHTHALMOLOGY (2008)
PREDICTORS OF ANTI-VEGF-ASSOCIATED RETINAL PIGMENT EPITHELIAL TEAR USING FA AND OCT ANALYSIS
Allen Chiang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity
Hugo Quiroz-Mercado et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection
John O. Mason et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
David R. Fintak et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
J. F. Arevalo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Twelve-month safety of intravitreal injections of bevacizumab (Avastin (R)): results of the Pan-American Collaborative Retina Study Group (PACORES)
Lihteh Wu et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
Frank A. Scappaticci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Clinical update: new treatments for age-related macular degeneration
Tien Y. Wong et al.
LANCET (2007)
Tears of the retinal pigment epithelium - An old problem in a new era
Louis K. Chang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
Visual hallucinations after intravitreal injection of bevacizumab in vascular age-related macular degeneration
Carsten H. Meyer et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
RPE tears affer pegaptanib treatment in age-related macular degeneration
Louis K. Chang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
Managing patients treated with bevacizumab combination therapy
MS Gordon et al.
ONCOLOGY (2005)
Share Paper
